NIH

A disease-associated mutation in a transporter protein impairs gut barrier function, leading to gastrointestinal disease and chronic infections.

The NCI program project grant is supporting multiple projects that aim to define fundamental biological principles about extracellular RNA signaling and the development and aggressiveness of colorectal cancer, the second leading cause of cancer death in the United States.

New insights on influenza genome packaging could guide strategies for interfering with the virus’s life cycle and ability to cause infection.

Variation in the levels of hormones called natriuretic peptides may contribute to racial differences in susceptibility to diabetes, suggesting that this hormone system may be a target for reducing risk of the disease.

Danny Winder and colleagues are teasing apart the actions of neurotransmitter receptors in a brain region linked to anxiety and addiction, with a goal of finding treatments for substance use disorders.

Henry Henderson, PhD, was one of 16 researchers selected to participate in the American Association for Cancer Research’s Early-Career Investigator Hill Day on Feb. 27 in Washington, D.C. While there, he met with U.S. Sen. Marsha Blackburn and discussed funding for the National Institutes of Health and the National Cancer Institute with a member of the senator’s health policy staff.

This is not the Jedi you're thinking of. This Jedi is a receptor that helps clear away dead neurons during development, and its loss changes the activity of dorsal root ganglia neurons, which could have implications for treating chronic pain.